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ABSTRACT  A procedure has been devised for isolation of triads (t-tubule/sarcoplasmic  reticu- 
lum  (SR) junctional complexes)  from  rabbit skeletal  muscle.  The procedure consists of prepa- 
ration  of  a heavy microsomal  fraction  followed  by two  sequential  90-min  sucrose  gradient 
centrifugations  to enrich  the triads.  A  pyrophosphate/phosphate/magnesium  buffer  system 
was introduced to decrease aggregation  in order to achieve effective separation. The preparation 
time is 12 h. Some differences between purified triads isolated  by two variants of this method 
are noted. The purity of the triad fractions has been estimated by particle counting to be in the 
vicinity of 50%. There  is good retention of morphology and Ca++-Ioading activity and enrich- 
ment in Na÷,K+-ATPase and adenylate cyclase. The triads are practically devoid of contractile 
elements,  mitochondria,  and free  plasmalemma,  and low in content of light SR. The  method 
for obtaining enriched triads is reproducible,  and  sufficient yields are obtained for structural, 
biochemical, and functional characterization. 
Muscle contraction and relaxation in skeletal muscle are reg- 
ulated by the intracellular concentration of Ca  ++. During ex- 
citation-contraction  coupling, Ca  ++ is released from the sarco- 
plasmic reticulum (SR) compartment elevating the Ca  ++ con- 
centration in the myoplasm, thereby triggering muscle contrac- 
tion (1). Relaxation involves the reuptake and storage of Ca  ++ 
by sarcoplasmic reticulum, which can be simulated, in vitro, 
and therefore has been characterized in depth (2). The physi- 
ological Ca++-release process is less readily simulated, in vitro, 
and is poorly understood in molecular or mechanistic terms. 
Of particular interest here is the intraceUular triad junction, 
purported  to  be  the  link between the  signal process  of the 
surface membrane (excitation) and the release of Ca  ++ from 
the terminal cisternae of the SR resulting in contraction. The 
isolation of triads,  1 which are junctional associations of trans- 
verse tubular invaginations  of the surface membrane with the 
1  The term triad derives from electron microscopy of muscle in which 
the transverse tubule is apposed between two terminal cisteruae of 
sarcoplasmic reticulum, each in  junctional  association. Throughout the 
text, the term "triad" will be used to denote a structure composed of 
one or more junctional  associations of transverse tubule with terminal 
cisteruae.  In this  context, triad  is  not intended  to  suggest that  it 
necessarily consists of three components but rather refers to a structure 
consisting of two or more components in junctional  association. 
terminal cisternae of the  SR,  could  make  possible in vitro 
simulation of the Ca++-release process, especially Ca  ++ release 
induced by transverse tubule depolarization. 
The  only procedures  in the  literature  that  deal  with  the 
isolation of triads are by CasweU  and co-workers (3, 4).  The 
fraction described was somewhat enriched in triads and was 
used mainly for the subsequent isolation of transverse tubule 
(4-7).  No  estimate of purity was  given. We now report the 
preparation of highly purified triad structures that retain ar- 
chitectural properties resembling that seen in situ (8-11). The 
purity of the fraction has been assessed by diagnostic marker 
enzyme assay and by particle counting. This paper describes 
the isolation procedures. A companion paper (11) emphasizes 
morphology and structural susceptibility of isolated triads to a 
variety of conditions. 
MATERIALS  AND  METHODS 
Materials 
Solutions were prepared in sequentially distilled and deionized water and all 
stock chemicals were reagent grade from Fisher Scientific Co. (Pittsburgh, PA) 
unless otherwise stated.  "Density gradient grade" sucrose was obtained from 
Schwarz/Mann Div., Becton, Dickinson & Co. (Orangeburg, NY) and from EM 
laboratories, Inc. (Elmsford, NY). All sucrose concentrations are given as percent 
sucrose (wt/wt), determined using a  Bausch and Lomb refractometer (Bausch 
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solutions was adjusted at room temperature to the values indicated. Radioactive 
a-labeled 32P-ATP for adenylate cyclase was prepared by the method of Walseth 
and Johnson (12) in Dr.  R. Johnson's laboratory at Vanderbilt University or 
obtained from New England Nuclear (Boston, MA), as was [all]cAMP (30-50 
Ci/mmole).  Myokinase, adenosine deaminase, arsenazo III  (~98%),  Na~ATP, 
and creatine phosphate were obtained from Sigma Chemical Co. (St. Louis, MO) 
while creatine phosphokinase was obtained from both Sigma and Boehringer 
Mannheim Biochemicals (Indianapolis, IN). 
New Zealand White rabbits (2-3 kg) were obtained from Hilltop Rabbits, Inc. 
(Columbia, TN). All centrifugation steps were performed with Beckman medium 
speed centrifuges 0-21) and ultracentrifuges with appropriate rotors. 
Assay Methods 
Protein concentrations were determined by the procedure of Lowry et al. (13) 
using bovine serum albumin as standard. Total phosphorus was measured by a 
modification of the  method of Chen  et  al. 04),  as described by Rouser and 
Fleischer (15), and provided an estimate of lipid phosphorus. Radioactivity was 
measured with a Searle Mark Ill scintillation counter with appropriate program- 
ming. 
Samples were prepared for thin-section electron microscopy as described in 
Mitchell et al. (l l) and/or Palade et aL (16). The former uses a small amount of 
sample to form a thin pellet that can be sectioned and viewed from top to bottom; 
the latter is a  filtration procedure that makes use of dextran to insure a  repre- 
sentative distribution of sample. 
ENZYME ASSAYS:  Samples from gradient centrifugation were diluted slowly 
over approximately one-half hour to  10% sucrose, sedimented with a  Type 35 
rotor (30,000 rpm for 60 min), and resuspended in 10% sucrose, 5 mM HEPES, 
pH 7.2 before assaying. Adenylate cyclase activity was determined by measuring 
the production of radioactive cAMP produced from a-a2P-ATP according to a 
modification of the method of Jakobs et al. (17). In our experience this activity 
is  stable  and  can  be  carried out  on  samples  frozen  and  thawed  one  time. 
Generally, assays were run for 5 min at 37°C. The assay medium contained final 
concentrations of 25 mM Tris-HCl (pH 7.5), 5 mM MgCI2;  I rnM  1-methyl-3- 
isobutyl xanthine (M.I.X.) was included to inhibit phosphodiesterase activity. An 
ATP-regenerating system, consisting of 25 U/ml myokinase, 12.4 U/ml creatine 
phosphokinase, 1 U/ml adenosine deaminase, and 20 mM creatine phosphate, 
was used to insure constant ATP concentration and to avoid buildup of compet- 
itive inhibitors. 
Ouabain sensitive Na+-K  + ATPase activity was titrated with SDS according 
to the method of Seiler and Fleischer (18). The sample (1 mg/ml) was pretreated 
with varying concentrations of SDS ranging from 0 to 0.3 mg/ml in a  medium 
containing 40 mM  imidazole-HEPES, 2  mM Tris-EDTA for 30 min at room 
temperature before enzyme assay. Ouabain sensitivity was assayed in the presence 
and absence of I raM ouabain. Reactions were started by the addition of sample 
(10-20 ~tl) to a 37°C assay mix containing 120 mM NaC1, 5 mM NAN3, 20 mM 
KC1, 3 mM MgC1.2, 0.5 mM EGTA, 3 mM Na2ATP in 30 mM imidazole buffer, 
pH 7.5 in a final volume of 0.5 ml. Reactions were allowed to proceed for 5-20 
min and were stopped by the addition of 0.5 ml of 5% SDS, 10 mM EDTA, and 
placing on ice. Phosphate production was measured by a  modification of the 
method of Baginski et al. (19). Ouabain-sensitive Na+-K  + ATPase was calculated 
as the difference between the amount of phosphate released in the presence and 
absence of 1 mM ouabain at the optimal SDS concentration, usually between 
0.17 and 0.23 mg SDS/ml. 
Succinate-cytochrome c  reductase  activity was  measured  as  described  by 
Fleischer and Fleischer (20) by measuring the increase in optical density at 550.5 
nm in the presence of cyanide at 32°C. 
Ca  ++ "loading" rates in the presence of phosphate were assayed using the 
metallochromic indicator arsenazo III (2 I) with a  Hewlett-Packard type 8450A 
spectrophotometer. Removal of calcium from the  medium was measured by 
following A66o-A740.  Samples (20-50 #g protein) were assayed at room temperature 
in the presence of 125 mM potassium phosphate buffer, pH 7.0, l mM MgCI2, 1 
mM Na2ATP, and l0 #M arsenazo III. Several loadings were made with 25 ,aM 
CaC12 additions per loading; further additions of calcium were made after all the 
calcium was taken up. Each addition served as its own internal calibration; in 
this regard the uptake of such additions required many tens of seconds, so that 
any uptake during this addition was negligible. The loading rates from such 
individual additions did not differ significantly and were averaged. 
RESULTS 
The procedure for triad isolation is described with two variants, 
standard and pyrophosphate.  These will be dealt with sequen- 
tially in the text, although the figures and tables may include 
data from both variants for comparison. 
The two variants were run side-by-side using portions of the 
same stock of rabbit muscle.  For each  preparation,  the hind 
leg  muscles  of a  single  rabbit  (~200-250  g)  were  utilized. 
Connective  tissue  fat,  nerve,  and  red  muscle  were  removed. 
The leg muscle was supplemented with back muscle (100-150 
g). The mixture was passed through a General model H  meat 
grinder fitted with a 2-mm hole mincing plate to obtain 300 g 
of ground muscle.  In total,  180  g  was  used  for the standard 
variant and 120 g for the pyrophosphate  variant. 
A.  STANDARD  VARIANT 
Packets  of 60  g  of ground  muscle  were  homogenized  in  a 
Waring Blender at top speed for  1 min in 300 ml of medium 
consisting of 10% sucrose, 0.5 mM EDTA, pH 7.2 (Fig.  1). The 
homogenate was centrifuged at 9,000 rpm for 15 min in a JA- 
10 rotor. The supernatant was filtered through cheesecloth and 
recentrifuged  at  14,000  rpm in  a  JA-14  rotor for  30  min  to 
produce  the  heavy microsome  fraction.  Microsomes  derived 
from  180 g  of ground muscle were resuspended in a  Dounce 
homogenizer with a loose fitting pestle in 15 ml of 10% sucrose, 
5 mM HEPES, pH 7.1. 
Preparation  of Stage I Gradient  (Triad- 
enriched)  Material 
Triads were enriched from microsomes by velocity gradient 
centrifugation.  A  combination  step  and  continuous  gradient 
was prepared (Fig.  2). Centrifugation was carded out using a 
precooled Beckman SW 27 rotor at 27,000 rpm (96,260 gay) at 
2-5°C  for 90 min (at speed).  The distribution  of material at 
completion of the run is shown in Fig. 2 (tube designated S). 
The  90-min  centrifugation  permitted  only  the  most  dense 
material  to approach  its  isopycnic  density,  resulting  in good 
separation of triad plasmalemmal activities from light SR and 
two  even  lighter  density  plasmalemmal  fractions  which  we 
previously described (22). Two main bands were well resolved. 
The  lower band was enriched  in  triads.  It consisted  of light 
brown  turbid  material  containing  visible  small  white  aggre- 
gates.  The  fraction  contained  substantial  levels  of adenylate 
cyclase activity (20-25 pmol/mg-min)  (Table IA). The Ca  +÷- 
phosphate  "loading"  was  roughly  half that  of the  light  SR. 
Examination  by  electron  microscopy  (not  shown)  indicated 
that the band contained a heterogeneous population including 
(a) intact triads (or dyads), (b) free "heavy" SR (24), (c) some 
free transverse tubule, (d) intact mitochondria, and (e) contrac- 
tile protein. The triad-enriched fraction accounted for 1~-20% 
of the total microsomal protein (See Table IA). 
The upper band designated "light"  SR layered at the inter- 
face between the 25% sucrose step and the continuous gradient 
(see Fig. 2). It exhibited much lower adenylate cyclase activity 
but  higher  rates  of calcium  phosphate  loading  (Table  IA). 
Electron microscopy of this fraction revealed mostly light SR 
vesicles  with  relatively  little  heavy  SR  and  few  triads  (not 
shown). 
Stage II Gradient Purification 
The major impurities in Stage I triad-enriched material were 
mitochondria and aggregated contractile material.  Separation 
of triads from mitochondria required dissociation of contractile 
elements, which was achieved using a pyrophosphate mixture 
(20 mM sodium pyrophosphate, 20 mM NaH2PO4, and 1 mM 
MgC12, pH 7. l) and a second velocity (90-min) centrifugation. 
The Stage I gradient triad-enriched material was diluted slowly 
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FIGURE  1  Flow diagram for isolation and purification of triads. Two 
variants  are  described.  The  standard variant  does  not  introduce 
pyrophosphate mixture until the slow dilution of the Stage I gradient 
triads. The pyrophosphate variant contains pyrophosphate mixture 
in all solutions at all stages. The pyrophosphate mixture contains 20 
mM  Na4P2OT, 20  mM  NaH2PO4,  and  1  mM  MgCI2,  pH  7.1. The 
asterisk  indicates  the  absence  of  pyrophosphate  mixture  in  the 
solutions for the standard variant. The Stage I gradient and separa- 
tion is illustrated in  Fig. 2 and is summarized in Table I. The Stage 
Jl gradient separation is shown in Fig. 3 and is summarized in Table 
II.  The  time  required  to  reach  the  stages  of  the  purification  is 
indicated on the left. The standard and pyrophosphate variants are 
discussed  sequentially in the text. 
A preparation of purified nontriadic SR can also be obtained 
as a  byproduct of the standard  variant. The upper "light" SR 
band  of the  first  stage  enrichment  is  applied  to  a  Stage  II 
gradient; residual adenylate cyclase activity concentrates in the 
LF4 fraction (Table II C), leaving low levels of contaminating 
plasmalemmal adenylate cyclase activity in LF3  fraction.The 
highest levels of Ca÷+-phosphate loading were found in Frac- 
tion LF3, which was generally 60% greater than that of Stage 
II purified triad and -  10% higher than that of Stage I light SR 
fractions.  Examination  by  electron  microscopy  (not  shown) 
indicated  that  this  traction  was  composed  predominantly  of 
vesicles without  electron-opaque  contents  and  was  therefore 
considered to be light SR. 
B.  PYROPHOSPHATE  VARIANT 
This procedure is similar to the standard variant method, except 
that  the  pyrophosphate  mixture  is  included  throughout  the 
purification.  Because  more  protein  is  suspended  during  ho- 
mogenization in the presence of the pyrophosphate mix, less 
ground  muscle  (40  g) was homogenized  for every 300  ml of 
medium containing 0.5  mM EDTA,  10% sucrose (wt/wt) and 
pyrophosphate mixture.  Otherwise,  the preparation of micro- 
somes employed the same centrifugation  steps as outlined  in 
Fig.  1 for the standard variant. The yield of microsomes was 
-1.6-fold higher in the pyrophosphate  variant compared with 
with pyrophosphate  mix to  10% sucrose,  pelleted,  and  resus- 
pended  in  pyrophosphate  mix  containing  10%  sucrose.  The 
sucrose step-gradient (Fig. 3) was fortified with the pyrophos- 
phate mixture. 
Protein  and  diagnostic  enzyme distribution  of the  Stage II 
gradient purification is detailed in Table IIA. Fractions F3, F4, 
and F5 contain the majority of the adenylate cyclase activity, 
and were enriched in triads as viewed by electron microscopy. 
Fraction F4, appearing at the 28/32% interface, displayed peak 
activity (50-65  pmol/mg, min).  Identification of this material 
as purified triads is shown in Fig. 4 a  by electron microscopy; 
more extensive quantitative data are presented later in the text 
(see Table IV). Fraction  F3 was contaminated with light SR, 
as  indicated  by  its  increased  Ca++-phosphate  loading  rates 
(Table  IIA)  and  by  electron  microscopy  (not  shown).  Both 
fractions F4 and F5 consisted mainly of, and were considered, 
purified  triads.  Fraction  F4  had  only  minor  mitochondrial 
contamination  (1.5%)  while  fraction  F5  contained  about  7% 
mitochondria  as measured by particle counting.  F4 appeared 
to be the more enriched of the two by adenylate cyclase and 
Ca÷+-phosphate loading activity. The combined protein yield 
of  fractions  F4  and  F5  is  5-6  mg/100  g  starting  muscle, 
accounting  for -60%  of the  adenylate cyclase activity of the 
Stage I triad-enriched starting material. 
FtGURE  2  Preparation of Stage I enriched triads by fractionation of 
skeletal muscle microsomes.  Purification of skeletal muscle micro- 
somes is carried out by 90-min centrifugation in a combination step 
and continuous sucrose gradient. The right-hand diagram shows the 
concentrations  of  sucrose  used  in  the  gradient.  Linear  gradients 
from  28 to 50% sucrose  were prepared 18.5 ml  using 5 mM  HEPES, 
pH 7.1  buffered solutions of 19% sucrose  (wt/wt)  and 57% sucrose 
(wt/wt)  using a Beckman gradient former. The continuous gradients 
were formed at room temperature using chilled solutions and were 
equilibrated overnight at cold room temperature before application 
of  the  step  gradient.  A  12-ml  step  of  25%  sucrose  (wt/wt)  was 
applied atop the continuous gradient followed by a second step (4 
ml) of 14% sucrose  (wt/wt) and 5 ml sample in 10% sucrose  (wt/wt) 
were placed on top of the gradient in an SW 27 rotor tube. Results 
are shown for both variants. S refers to Stage I standard purification 
in 5 mM  HEPES and sucrose,  pH 7.2.  P refers  to Stage  I pyrophos- 
phate  purification  in  20  mM  Na4P2Or,  20  mM  NaH2PO4,  1  mM 
MgCl2 and sucrose.  Jn each case, the lowest lying band in the tube 
is the Stage I enriched triad fraction. In the standard preparation the 
light SR and triad/mitochondrial fractions are clearly separated. For 
the pyrophosphate variant the two bands are less well resolved. The 
light SR fraction  is located above and appears whiter. The triadic/ 
mitochondrial  fraction  is immediately below and  is whitish  in  ap- 
pearance at the top and orange-brown at the bottom. 
1010  THE JOURNAL OF  CELL BIOLOGY - VOLUME 96, 1983 TABLE  I 
Summary of Stage I Gradient Fractionation 
Recovery  Enzymic  activity 
Succinate-cyto- 
% of micro-  Ratio of protein  Adenylate  Ca++-Phos  -  chrome  c 
Tissue  somal  protein  triads/light  SR  cyclase  phate Loading  reductase 
mg/lOOg  pmol/mg.min  i~mol/mg.min  nmol/mg.min 
A. Standard  Variant 
Light SR  21.3 4- 3.7  21.7 +  4.2  0.85 4- 0.21 
Enriched  triadic  material  17.9 4- 4.1  18.2 +  4.9 
B. Pyrophosphate  Variant 
Light SR  31.9 +  5.9  21.1  ±  6.7 
2.O4 ±  0.23 
Enriched  triadic  material  64.4 ±  10.7  40.7 +  7.1 
5.6 +  1.2  3.45 +  0.56  7.5 4- 3.3 
21.4 +  2.6  1.56 -i- 0.05  79.3 +  24.4 
Variable  1.94 +  0.56  51.3 +  15.3 
15.6 ±  2.2  1.04 +  0.04  130.0 4- 13.0 
A summary of Stage I enrichment of triads.  Four successive preparations of Stage I light SR and triad-enriched material were isolated and assayed for protein and 
enzymic activities. The results are expressed as the mean with  standard deviation. The gradient purification  is shown in  Fig. 2. Standard  and  Pyrophosphate 
variants are compared.  Yields were normalized  for 100 g  of ground white  muscle  and  are expressed in  terms  of mg  obtained/1OO g  ground  muscle,  % of 
microsomal protein, and the ratio of protein in triad to light SR functions. Adenylate cyclase was assayed at 37°C as an index of transverse tubule. Rates of 375 
pmol/mg rain have been obtained in our laboratory for transverse tubule isolated using the French Pressure cell technique of Lau et al. (4) for disruption of triads 
and subsequent gradient centrifugation. Comparable rates (313 pmol/mg  rain) have been reported for purified surface sarcolemmal vesicles from rabbit skeletal 
muscle  (18). Phosphate facilitated calcium "loading" was assayed as an index of sarcoplasmic reticulum  Purified light SR exhibits a rate approaching 4-5/~mol/ 
mg. min when assayed promptly after preparation and without freezing. The determinations shown here were performed on material frozen and thawed once 
and are, therefore, less than optimal  in activity. The mitochondrial marker enzyme, succinate-cytochrome c reductase activity was assayed at 32°C.  In order to 
estimate mitochondrial contamination, a rate of 800-900 nmol/mg.min  (20, 23) was used. 
FIGURE  3  Stage II gradient purification  of triads using standard  (S) 
and pyrophosphate (P) variants. The sucrose step gradient employed 
is shown  in the diagram at the right.  Stage I triad-enriched  material, 
in  hypertonic  sucrose from  the gradient,  was diluted  slowly  (30-45 
rain) with  the pyrophosphate mixture to a sucrose concentration  of 
8-12%,  using  gentle  stirring.  The  diluted  material  was  sedimented 
(Type  35  rotor,  60  rain  at  30,000  rpm)  and  resuspended  in  the 
pyrophosphate mixture containing 10% sucrose (wt/wt)  and applied 
to a discontinuous  sucrose gradient.  The gradient  was constructed 
with  steps of 0.5 ml 45%, 4.5 ml  36%, 6  ml  34%,  6  ml  32%, 6  ml  28%, 
6  ml  25%,  and  4  ml  15%  sucrose.  Each  step  was  fortified  with  the 
pyrophosphate  mixture.  Sample,  equivalent  to  one SW  27  tube  of 
gradient  I,  was  applied  in  5  ml,  and  velocity  centrifugation  was 
carried out  at 27,000 rpm  for 90 rain at 2-5°C  using a  Beckman  SW 
27  rotor.  The distribution  of material  in  the gradient  after centrifu- 
gation  is shown.  Stage  II  gradients  for both  variants contain  pyro- 
phosphate mix. Band positions of fractions are indicated  to the right 
of tube  P.  Purified  triads are located  in  fractions  4  and  5.  Enzymic 
characterization  of the fractions  in  the gradient  is given  in Table II. 
the  standard  variant  (calculated  from  Table  I).  Microsomes 
from  120 g  of ground  muscle were  resuspended  in  15  ml of 
10% sucrose containing pyrophosphate mixture. 
The Stage I gradient separates microsomes into two partially 
resolvable  bands  (Fig.  2,  tube  labeled  P).  The  separation  of 
triads is incomplete and accounts for the variability in adenyl- 
ate cyclase activity found in the upper band (Table I B).  The 
lower band comprised  -40% of the  total microsomal protein 
(Table I B) and was found by electron microscopy to primarily 
contain  triads,  mitochondria,  and  contractile  aggregates  (not 
shown). Compared with the standard variant, the yield of triad- 
enriched  material  was  3.5-fold  greater,  although  adenylate 
cyclase specific activity was  consistently  ~30%  lower  (Table 
I B). The Stage I gradient triad-enriched  material was diluted 
slowly with pyrophosphate mix to  10% sucrose, pelleted,  and 
resuspended in pyrophosphate mix containing  10% sucrose. 
The second stage gradient purification of the pyrophosphate 
variant was carried  out  as in  the standard  variant  except for 
application of more sample. The separation pattern was similar 
(Fig. 3, tube labeled P). Table I! B demonstrates that adenylate 
cyclase specific activity was again highest in the 28/32% inter- 
face fraction (F4), which consisted predominantly of morpho- 
logically well-preserved triads (Fig. 4 b). From the standpoint 
of  yield, the final purified F4 triad fraction of the pyrophosphate 
variant was fourfold greater than that from the standard prep- 
aration, normalized per 100 g of starting ground muscle. Sub- 
stantial adenylate cyclase levels were also found in F5, which, 
compared  with  F4,  displayed  higher  succinate-cytochrome  c 
reductase levels and lower Ca+÷-phosphate loading rates.  ~ 10 
mg  of F4  material,  or  25  mg  of F4  and  F5  together,  were 
isolated with the pyrophosphate  variant from 100 g of starting 
ground muscle. Curiously, the adenylate cyclase specific activ- 
ities  were  only  about  half as  high  as  those  of the  standard 
variant. 
COMPARISON  OF  TRIAD  FRACTIONS 
Diagnostic enzymic activities of triad fractions prepared by the 
two variants of the current purification procedure and by two 
other methods are compared in Table III. From the standpoint 
of adenylate cyclase activity, the Stage I gradient enriched triad 
material from both  variants  are  in  the  same range,  although 
that  from  the  standard  variant  is  significantly  higher.  Each 
Stage II gradient procedure results in enhanced cyclase activity, 
although purified  triads prepared by the standard variant ex- 
hibit approximately twofold higher specific activity of adenyl- 
ate cyclase than those prepared by the pyrophosphate  variant. 
Na, K-ATPase, another diagnostic for transverse tubule (4), 
demonstrated similar enhancement of levels through a second 
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Stage II Purifications of Triads and Light Sarcoplasmic Reticulum 
Protein  Enzymic  activity 
Adenylate cyclase  Ca++-Ph°sphate  Succinate-cyto- 
loading  chrome  c  reductase 
% sucrose at  pmol/mg.  /~mol/mg.  % of  nmol/mg.  % of 
Fraction  interface  mg  % of Total  rain  % of Total  rain  Total  min  Total 
A. Summary of Stage II gradient purification  of enriched triads prepared by the Standard variant 
Stage I  --  16.00  100.0  28.3  100.0 
Stage II 
F1  10/15  0.43  2.7  ND  --  ND 
F2  15/25  0.51  3.2  7.0  1.0  N D 
F3  25/28  1.26  7.8  24.2  8.5  2.91 
F4 (triads)  28/32  2.35  14.7  56.1  36.9  1.81 
F5 (triads}  32/34  2.99  18.7  28.6  23.9  1.15 
F6  34/36  3.49  21.8  8.6  8.4  0.92 
F7  36/45  1.58  9.8  4.8  2.1  1,12 
Recovery  78.7  80.8 
B. Summary of Stage II gradient purification  of enriched triads prepared by the  Pyrophosphate  variant 
Stage I  --  68.40  100  15.7  100.0  1.0 
Stage II 
F1  10/15  2.09  3.0  33.0  6.5  N D  --  39.0  0.8 
F2  15/25  2.85  4.2  10.1  2.7  N D  --  33.0  1.0 
F3  25/28  6.52  9.5  16.8  10.2  ND  --  27.5  1.9 
F4 (triads}  28/32  10.72  15.7  27.1  27.2  1.41  15.1  35.5  4.0 
F5 (triads}  32/34  16.00  23.4  23.5  35.0  0.56  9.0  82.5  14.0 
F6  34/36  12.56  18.4  ND  --  0.63  7.9  302.5  40.4 
F7  36/45  8.85  12.9  N D  --  0.70  9.2  468.5  44.0 
Recovery  87.1  >81.6  106.1 
C. Summary of Stage II gradient purification  of light SR prepared from the Standard variant 
Stage I  --  28.90  100.0  4.8  100.0  4.9  100.0  6.4  100.0 
Stage II 
L F3  25/28  9.54  33.0  2.2  15.1  5.2  34.9  8.6  44.0 
L F4  28/32  9.07  31.3  12.1  79.1  3.7  23.6  7.6  37.2 
1.61  100.0  118.9  100.0 
--  34.3  0.0 
--  40.0  1.3 
14.2  25.4  2.1 
16.5  15.5  2.4 
13.3  52.5  10.4 
12.5  163.8  38.1 
6.8  349.9  36.8 
91.1 
100.0  137.5  100.0 
Stage II gradient purification of triads. Stage I triad material from Standard and Pyrophosphate variants was further purified using Stage II gradient purification 
(Fig.  3).  The amount  of Stage I triad  material  recovered from  100 g of ground  muscle  is given as Stage I  (protein). A  total  of six SW  27 tubes (applying 
approximately 20 mg and 60 mg protein per tube for Standard and Pyrophosphate variants, respectively) is convenient for a single preparation involving one or 
two  rabbits and one SW  27 rotor for both the  Standard and  Pyrophosphate variants. The fractions were assayed for protein, adenylate cyclase,  phosphate 
facilitated calcium loading, and succinate-cytochrome c reductase.  Protein and Ca÷+-phosphate loading are values obtained from a single preparative run while 
succinate-cytochrome c reductase and adenylate cyclase are values averaged from several preparations. All assays were carried out on samples that were quick- 
frozen and singly thawed, except for the phosphate-facilitated loading in Table II C, which was performed on fresh material after the second stage of purification 
of light SR by the Standard variant. Purified triads, Stage II  Standard (F4), assayed fresh without freezing and thawing, demonstrate Ca+*-Ioading rates of 2.5-3 
~mol/min. mg protein. The reduction in activity revealed in Tables II A and II B is the result of assaying material that was frozen in the absence of 0.1 M  KCl; the 
latter is required for stabilizing activity (25).  ND, not determined. 
stage of purification.  However, for this enzymic activity, the 
purified triads from the pyrophosphate  variant have more than 
twofold higher specific activity than the purified product from 
the standard variant. The calcium-phosphate loading rates of 
the purified triads (F4 fractions) from both variants are similar. 
ELECTRON  MICROSCOPIC  ASSESSMENT  OF 
TRIAD  PURITY 
Attempts have also been made to quantitate the triad content 
of fractions from both the standard and pyrophosphate variants. 
Triad fractions were prepared  from four consecutive runs of 
both standard and pyrophosphate  variants  (Stage  I  gradient 
triad  fraction,  and  Stage  II gradient,  Fractions  F4  and  F5). 
Quantitation of vesicle types and number were made by thin- 
section electron microscopy. To facilitate quantitation, a filtra- 
tion procedure was developed that makes use of  high molecular 
weight dextran as a nonosmiophilic spacer substance (16). This 
method insures uniform sample distribution permitting quan- 
titation  without necessitating  sectioning entirely through the 
pellet, as is required for pellets obtained by centrifugation. In 
one instance,  in which both  methods of sample  preparation 
were compared, essentially similar results were obtained. 
Only  vesicular  structures  were  counted,  2 and  these  were 
segregated into the categories shown in Table IV. The identi- 
fication  of junctional  structures  involved  subdivision  into 
"probable" and "possible" categories (cf. Legend, Table IV) in 
order to  reduce  observer bias.  Half or more  of the  vesicles 
counted in both standard and pyrophosphate  Stage II, F4 frac- 
tions  fell  into  the  "probable" junctional  structure  category, 
which averaged 1.5 terminal cisternae per transverse tubule. 
Particle counting (Table IV) confirms enzymic data (Tables 
IIA and III) indicating a further enrichment of standard triads 
by the second stage of purification,  but it  does not reflect a 
similar purification for the second stage of the pyrophosphate 
variant.  Particle  count  comparison  of standard,  F4  and  F5 
fractions suggests greater similarity than do the enzymic data 
2 Contractile protein was observed as a minor contaminant in Stage I 
preparations of both variants but was not evident in purified Stage II 
triads. 
1012  THE  JOURNAL OF  CELL BIOLOGY • VOLUME 96, 1983 FIGURE  4  (a)' Electron microscopy of a representative section Stage II gradient fraction 4 triads prepared according to the standard 
variant. The triads were fixed with glutaraldehyde in suspension and filtered according to (16)  to ensure representative sampling. 
A  representative field is shown, x  45,000.  Material enclosed by square is considered a "probable" junctional structure (i.e. terminal 
cisternae  and  transverse tubule  are juxtaposed  appropriately to  suggest  junctional  association  and  are  in  the  field  of  focus). 
Material enclosed  by circle  is considered a "possible"  junctional  structure  (see legend to Table  IV).  (b)  Electron  microscopy of 
Stage II gradient, fraction 5 triads prepared according to the pyrophosphate variant, x  45,000. 
1013 TABLE  III 
Comparison  of Enzymic Characteristics of Isolated  Triad 
Fractions Obtained by Different Procedures 
Ca ++  Phos- 
Adenylate  phate 
Na,K-ATPase  cyclase  "loading" 
#mol/mg.h  pmol/mg.  #mol/mg. 
rain  rain 
I.  Isopycnic enrich-  ND  13.0 +  7.0  ND 
ment by Caswell 
et al. (3, 5) 
II.  KCI preparation 
(30) 
Stage I  ND  17.4 +  3.2  ND 
enrichment 
(isopycnic) 
Purification  (Stage  ND  41.2 ±  4.4  ND 
II gradient) 
III A. Standard  variant 
Stage I  0.96 +_ 0.19  21.4 ±  2.6  1.56 ±  0.05 
enrichment 
Purified  triads  2.16 ±  0.79  57.5 ±  8.5  1.35 +  0.20 
(Stage  II gra- 
dient) 
III  B.  Pyrophosphate 
variant 
Stage I  2.76 +  0.03  15.6  +  2.2  1.04  +  0.04 
enrichment 
Purified triads  4.96 +  0.63  27.1  +  7.0  1.43  ±  0.20 
(Stage II gra- 
dient) 
Comparison of enzymic characteristics  of isolated  triad fractions obtained by 
several different procedures.  Procedure  III A  and  III  B are described  in the 
text. The Stage II triad fractions given in the table are Fraction 4 (Table IlL The 
Na,K-ATPase and adenylate cyclase assays were carried  out at 37°C while the 
Ca++-phosphate  loading  was  at  25°C.  The  only  triad  fractionation  in  the 
literature is the isopycnic purification of Caswell  et al. (3, 4). The first  stage of 
the  KCI preparation  (30) has some  similarity  to the Caswell  preparation  in 
that it involves an  isopycnic sucrose gradient of microsomes  in  the absence 
of KCI. The second  stage of purification  employed 0.7 M  KCI in the gradient 
to disaggregate  contractile protein during a 2.5-h centrifugation  (30). Limited 
enzymic  data  is  available  for  the  Caswell  fraction,  which  has  been  used 
primarily as an intermediate for transverse tubule isolation. Transverse tubule 
isolated  by Lau et al. (4) was reported to have a Na, K-ATPase activity of 6.18 
#mol/mg.h  when assayed in the presence  of Nal  at 37°C. Transverse tubule 
isolated  in our laboratory in a manner similar  to Caswell  from purified triads 
prepared  by the Standard variant gave a Na, K-ATPase rate of 39 p,  mol/mg.h 
and 375  pmol/mg.min  for  basal  adenylate cyclase  activity. Maximal  Na,K- 
ATPase activity was measured  using optimal SDS concentrations as described 
in the Materials and Methods. ND, not determined. 
(Table IIA), but a similar comparison ofpyrophosphate Stage 
II F4 and F5 fractions corresponds with the similarity of the 
two fractions enzymically (Table IIB). 
Comparison of  particle counts of standard andpyrophosphate 
Stage II gradient fractions (F4) suggests that the purified triad 
fractions were similar (Table IV). We cannot explain by elec- 
tron microscopic quantitation either the higher cyclase activity 
of  the standard preparation or the higher Na, K ATPase activity 
of the pyrophosphate preparation  (Table  III).  Nevertheless, 
both  the  enzymic and  morphological data  suggest  that  the 
purified triads are highly enriched (~50%). 
DISCUSSION 
The isolation of a subcellular structure is an important step in 
its  biochemical  and  functional characterization.  Thus  far,  a 
purified preparation of triads has not been available. We now 
report the development of a procedure for the isolation of a 
fraction highly enriched in triads,  The purity is estimated by 
particle counting to be in the vicinity of 50% (Table IV). The 
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isolated triads retain considerable architectural detail (11) char- 
acteristic of that observed in intact tissue (8-10), including the 
junctional feet structures that join transverse tubule  and ter- 
minal cisternae (11). 
The  only previous  work  concerned  with  the  isolation  of 
triads is by Caswell et al. (3) who achieved some enrichment of 
triads  from a  microsomal fraction of rabbit  skeletal  muscle. 
The fraction was used mainly for the isolation of transverse 
tubule (4). Their study served to direct attention to the prepa- 
ration of triads but did not include any quantitation that would 
permit an evaluation of enrichment or purity. In the six years 
that followed, no report of the purification of triads has ap- 
peared  in  the  literature,  although  more  recently  Caswell's 
laboratory reported studies involving junctional reassociation 
(6,  26,  27)  between  purified  transverse  tubule  and  terminal 
cisternae. 
The isolation of triads from rabbit skeletal muscle described 
here is straightforward and reproducible. The procedure con- 
sists  of the preparation of a  "heavy microsome" fraction and 
two  sequential  90-rain  gradient  centrifugations.  The  entire 
procedure  takes  about  12  h.  The  method  yields  adequate 
amounts of sample  for biochemical study. The muscle from 
one rabbit will yield ~ 15 or 75 mg of purified triads (combined 
F4 and F5) by the standard or pyrophosphate variants, respec- 
tively. 
The most critical problem in triad  isolation was to devise 
conditions to disaggregate membrane components in order to 
achieve purification by centrifugation. The aggregation appears 
to be referable to contractile proteins and is therefore a problem 
inherent in the purification of membrane fractions from mus- 
cle.  Most preparations  of sarcoplasmic reticulum or plasma- 
lemma from skeletal muscle make use of a salt presoak con- 
taining high concentrations of KC1 or LiBr (22,  24,  28,  29). 
Initially,  we used  0.6-0.7  M  KCI (30),  which enabled us to 
achieve separation  and good purification of triads  based on 
enzymic criteria, but the morphology was severely altered (11, 
30). 
Early work by Hasselbach and Schneider (31) and Hanson 
and Huxley (32) recognized that pyrophosphate could be used 
to solubilize actomyosin. Mg  ++ was found to be essential for 
the dissociation process (33). More recently, pyrophosphate has 
been  used  in  the  isolation  of sarcolemma  and  sarcoplasmic 
reticulum from heart muscle (34--38). The application of py- 
rophosphate to the purification of triads required £me-tuning. 
In an effort to effectively solubilize actomyosin aggregates, a 
variety of PPi/Mg  +÷ combinations were substituted  for KC1. 
Low levels of PPi (20 raM) were sufficient to break up acto- 
myosin complexes for purification of triads.  At higher levels 
(50 mM PPi/I mM MgClz), swelling of the terminal cisternae 
portion of the triad was observed with loss of contents, similar 
to  that  seen  (30)  with  high  concentrations  of KCI.  In  our 
experience, pyrophosphate from different batches and sources 
(Fisher  Scientific  Co.  and  Alfa  Div.,  Ventron  Corp.)  can 
behave  somewhat  differently  so  that  minor  adjustment  in 
concentration with a new batch of reagent may be necessary 
for optimization. Some MgCI2 was required for the procedure 
to be effective, although MgCI2 concentrations in excess of 1 
mM  caused  gross  aggregation.  The  pyrophosphate  mixture 
described was satisfactory for dissociating contractile elements, 
enabling separation of membrane components with  retention 
of triad morphology. 
Two variants have been described for preparation of triads 
that  differ  mainly  with  regard  to  when  the  pyrophosphate TABLE  IV 
Morphological  Quantitation  of Stage I and Stage II Gradient  Fractions  Obtained  by Standard and Pyrophosphate  Variants  of the Triad 
Isolation  Procedure 
Junctional  structures  Nonjunclional  structures  Other structures 
Probable  Possible 
TC  t-Tubule  TC  t-Tubule  TC  t-Tubule 
Small empty  Large empty 
vesicles (LSR)  Mitochondria  vesicles (PM) 
A. Standard  variant 
Stage I  18.9 +  5.8  15,5 5:4,1  13.9 5:2.5  13.8 ±  3.5  4.7 ±  1.6  2.83 ±  0.77  16.7 ±  1,07  8.04 ±  2.66  1.06 ±  0.89 
Stage  II 
Fraction  4  31.1±3.3  21.4±3.0  15.4±8.0  77±3.3  11.8±3.8  2.28±0.61  6.56±2,61  1.67±0.80  0.43±0,28 
FractionS  283±3.9  19.0±2.8  14.4±2.2  12.0±1.3  11.6+2.7  2.72±1.36  2.94 ±  1.60  6.78±2.05  0.25±0.20 
B. Pyrophosphate  variant 
Stage  I  31.8 ±  5.0  22.1 5:1.6  8,8 5:0.3  7.9 ±  0.4  9.4 5:2.0  1  30 ±  1.05  7.81 ±  1.55  5.70 ±  1.92  0.47 5:0,22 
Stage II 
Fraction 4  33.3 _+ 3.1  21.8 ±  3.4  13.7 ±  3.3  10.7 ±  2.5  12.7 ±  3.6  2.57 ±  0.84  3.35 ±  0.69  0,83 -e 0.32  0.24 5:0.18 
Fraction 5  34.9 5:3.2  25.1 ±  2.8  10.1 ±  1.8  7.9 5:1.2  121 ±  4.5  2.19 ±  1.03  3.43 ±  1.94  3.02 ±  0.65  0.18 ±  0.35 
Morphological quantitation of Stage I and Stage II triad fractions by particle counting,  Four consecutive preparations of Standard  and Pyrophosphate  triadic material were filtered according 
to (16)  to obtain  representative samples.  Electron micrographs  of representative fields were independently  tallied  by two investigators (R D. Mitchell  and  P. Palade).  Between 1,000 and 
3,000 vesicles were counted  for each fraction.  Terminal  cisternae and  transverse tubule  can  readily  be resolved  morphologically.  ]he term junctional  structures  refers  to t-tubule  and 
terminal cisternae, oriented with  respect  to one another so as to suggest  iunctional  association Triad material is classified as junctional  material and  is distinguished  from nonjunctional 
triad components  (i.e.,  free transverse  tubule  and  terminal cisternae  [TC]). Apposed  transverse  tubule  and  TC that were clearly visible with  all  portions of the structure  in the plane of 
section were tallied as probable  junctional structures,  even if bridging structures were not clearly evident. Possible  junctional structures refers to less certain identification in which t-tubule 
or terminal cisternae are identifiable and positioned near material that was out of the plane of section. See text for further discussion of morphological criteria for contaminating structures. 
Values,  which  appear in each category,  are given as the  percentage of all the vesicles  counted  for each fraction  Such  values do not  reflect  the greater protein  mass of some structures 
compared with others, 
mixture  is  introduced.  The pyrophosphate variant  contained 
pyrophosphate mixture in all solutions beginning with homog- 
enization, whereas the standard variant contains solutions for- 
tified  with  pyrophosphate  mixture  beginning  with  the  slow 
dilution of Stage I gradient  triads.  The early introduction of 
pyrophosphate gives a  higher recovery of microsomes, and a 
four- to fivefold greater yield of triads.  The pyrophosphate as 
compared with the standard variant is characterized by a higher 
Na,K-ATPase and  lower adenylate cyclase at  both stages of 
gradient  purification.  The  basis  for such  differences  will  be 
dealt with in a later communication (Mitchell, R. D., P. Volpe, 
P,  Palade,  and  S.  Fleischer,  manuscript  submitted  for publi- 
cation.). 
A  variety of contaminants  must  be  separated  from triads 
including  contractile  protein,  mitochondria,  and  nontriadic 
sarcoplasmic reticulum and transverse tubule.  A  "heavy" mi- 
crosome fraction  was  obtained  in  order  to  reduce  light  SR 
contamination, even though the content of mitochondria and 
contractile protein initially may have been higher. Of the two 
variants  described,  the pyrophosphate microsomes  contained 
more  triads  and  mitochondria  and  less  light  SR.  Velocity 
gradient centrifugation was effective for further purification in 
the standard Stage I enrichment.  The two bands in pyrophos- 
phate  Stage  I  separation  were  less  well  separated,  but  the 
procedure was still effective to remove most free light SR from 
the triad-enriched material. 
The mitochondrial contamination in our Stage I fraction is 
aggregated together with the triads and requires disaggregation 
conditions  for  further  purification.  A  simple  discontinuous 
sucrose gradient containing pyrophosphate mixture was effec- 
tive in achieving the Stage II purification. As long as conditions 
for disaggregation were used, plasmalemma and free transverse 
tubule remained at the top of the gradient. The purified triads, 
especially Fraction 4, have only minor contamination by mi- 
tochondria (< 1.7%), light SR (<6.6%) and larger vesicles prob- 
ably of plasma membrane origin (<0.5%) as judged by particle 
counting by electron microscopy (Table  IV).  The low mito- 
chondrial contamination is confirmed by marker enzyme assay 
(Table II). Fraction 5, though slightly less pure, is a respectable 
triad  preparation  as  well,  particularly  in  the pyrophosphate 
variant (Fig. 4 b). 
At present,  no enzymic property has been localized histo- 
chemically that is biochemically unique to the triad structure 
and not to either of its component membranes, the transverse 
tubule or sarcoplasmic reticulum. Since triads could potentially 
co-isolate  in  regions  of sucrose  gradients  containing  sarco- 
plasmic reticulum, we employed transverse tubule markers, i.e., 
Na, K-ATPase and  adenylate cyclase, which have been vali- 
dated as simple diagnostics for triads by the work of Caswell 
and his colleagues (4, 5, 7). However, transverse tubule enzymic 
activities are shared by other sources of muscle and nonmuscle 
plasma membrane. A second consideration is that optimizing 
for even valid marker enzymes for transverse tubule and  SR 
does not necessarily insure  that  these  structures  are in junc- 
tional association or retain good morphology. Thus, quantita- 
tion at the level of the electron microscope was used to check 
the  purity  of our  fractions.  The  proportion  of junctionaUy 
associated vesicles in both standard and pyrophosphate Stage II 
gradient F4 fractions was estimated to be in the vicinity of 50%. 
Enzymic and electron microscopy criteria lead to somewhat 
different estimates of purity of the triads in comparing some of 
the fractions. This is because both methods, although the best 
available, are inadequate to the task. Both reflect uncertainties 
that are limiting. Particle counting is somewhat subjective with 
regard to triad identification; further, it counts the number and 
ignores size.  Differences in soluble  adventitious  or compart- 
mental  protein  are  not  considered  by particle  counting  but 
markedly  alter  the  specific  activity  by enzymic criteria.  An 
additional  problem is that the two diagnostic enzymes for t- 
tubule, adenylate cyclase and Na,K-ATPase, may be subject to 
differential inactivation during purification (Mitchell, R. D., P. 
Volpe, P. Palade,  and S. Fleischer, manuscript submitted for 
publication). 
Our standard and pyrophosphate procedures differ only in 
the extent of pyrophosphate exposure during preparation.  At 
this point in time we have insufficient data available  to rec- 
ommend  one  variant  over  the  other,  despite  certain  clear 
enzymic  differences.  In  both  cases,  the  morphology of the 
purified triads is similar and resembles that of the structure in 
vivo. A highly enriched triad preparation is now available that 
may open the door to studies attempting to simulate a t-tubule 
mediated  calcium release  process in vitro.  We have also de- 
MITCHELL et  At.  Triad Isolation and Characterization  1015 scribed the preparation of a defined fight SR fraction, isolated 
under similar conditions  to the triads,  which may provide  an 
important control for such Ca++-release  studies. 
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